Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2005 Jun;252(6):687-97.
doi: 10.1007/s00415-005-0718-y. Epub 2005 Mar 9.

Discrepancy between clinical and pathological diagnoses of CBD and PSP

Affiliations
Case Reports

Discrepancy between clinical and pathological diagnoses of CBD and PSP

Toshiki Mizuno et al. J Neurol. 2005 Jun.

Abstract

Progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) are often clinically confused with each other. Moreover, the discrepancy between clinical and pathological diagnoses of CBD and PSP are still controversial. We report here two atypical cases of PSP and CBD. A 73-year old woman was admitted with right hand rigidity, limb kinetic apraxia and cortical sensory loss. Brain atrophy, hypoperfusion and hypometabolism predominantly in the left frontoparietal lobes indicated CBD clinically. Pathological studies revealed neuronal loss and spongy change without ballooned neurons (BN) in the cerebral cortex. Modified Gallyas-Braak (G-B) staining revealed neurofibrillary tangles (NFTs) and tufted astrocytes, indicating pathological diagnosis of PSP. A 75-year-old man admitted with vertical gaze palsy, neck dystonia, parkinsonism and dementia. Atrophy of the frontal lobes and tegmentum of the midbrain and symmetrical frontal hypoperfusion in SPECT indicated PSP. However, neuronal loss and BN in the frontal lobes and clusters of astrocytic plaques indicated CBD pathologically. The G-B staining was useful for differentiating between CBD and PSP, but our atypical cases bring up a new issue about differential diagnosis of CBD and PSP.

PubMed Disclaimer

Similar articles

Cited by

  • Pathological laughter as onset symptom in atypical parkinsonisms.
    De Rosa A, Pappatà S, Peluso S, Saccà F, Lieto M, Filla A, De Michele G. De Rosa A, et al. J Neurol. 2017 Jan;264(1):182-184. doi: 10.1007/s00415-016-8351-5. Epub 2016 Nov 24. J Neurol. 2017. PMID: 27885486 No abstract available.
  • Which ante mortem clinical features predict progressive supranuclear palsy pathology?
    Respondek G, Kurz C, Arzberger T, Compta Y, Englund E, Ferguson LW, Gelpi E, Giese A, Irwin DJ, Meissner WG, Nilsson C, Pantelyat A, Rajput A, van Swieten JC, Troakes C, Josephs KA, Lang AE, Mollenhauer B, Müller U, Whitwell JL, Antonini A, Bhatia KP, Bordelon Y, Corvol JC, Colosimo C, Dodel R, Grossman M, Kassubek J, Krismer F, Levin J, Lorenzl S, Morris H, Nestor P, Oertel WH, Rabinovici GD, Rowe JB, van Eimeren T, Wenning GK, Boxer A, Golbe LI, Litvan I, Stamelou M, Höglinger GU; Movement Disorder Society-Endorsed PSP Study Group. Respondek G, et al. Mov Disord. 2017 Jul;32(7):995-1005. doi: 10.1002/mds.27034. Epub 2017 May 13. Mov Disord. 2017. PMID: 28500752 Free PMC article.

References

    1. Acta Neuropathol. 1994;88(2):113-21 - PubMed
    1. Arch Neurol. 1968 Jan;18(1):20-33 - PubMed
    1. Arch Neurol. 1964 Apr;10:333-59 - PubMed
    1. Ann Neurol. 1996 Dec;40(6):893-900 - PubMed
    1. Acta Neuropathol. 1998 Oct;96(4):401-8 - PubMed

MeSH terms

LinkOut - more resources